Our data demonstrate that ELA may prevent DOCA/salt-induced hypertension by blocking NADPH oxidase/ROS/NLRP3 signaling pathway in the kidney, which is APJ independent. The gene discussed is NLRP3; the disease is hypertensive disorder.